These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 30361964)

  • 1. Effects of parathyroidectomy on blood bone markers and heart rate variability in patients with stage 5 chronic kidney disease.
    Chen H; Cui Y; Xing C; Purrunsing Y; Zha X; Shen C; Zeng M; Yang G; Yu X; Zhang L; Jiang Y; Shen Z; Ma H; Yin C; Li Y; Wang N
    Int Urol Nephrol; 2018 Dec; 50(12):2279-2288. PubMed ID: 30361964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma FGF23 levels and heart rate variability in patients with stage 5 CKD.
    Zhang LN; Yang G; Cheng C; Shen C; Cui YY; Zhang J; Zhang JJ; Shen ZX; Zeng M; Ge YF; Sun B; Yu XB; Ouyang C; Zhang B; Mao HJ; Liu J; Xing CY; Zha XM; Wang NN
    Osteoporos Int; 2015 Jan; 26(1):395-405. PubMed ID: 25224292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism.
    Lu KC; Ma WY; Yu JC; Wu CC; Chu P
    Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroidectomy leads to decreased blood lead levels in patients with refractory secondary hyperparathyroidism.
    Chu P; Wu CC; Chen CC; Lu KC
    Bone; 2012 May; 50(5):1032-8. PubMed ID: 22373954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Parathyroidectomy on Plasma iPTH and (1-84) PTH Levels in Patients with Stage 5 Chronic Kidney Disease.
    Huimin C; Ying C; Changying X; Xiaoming Z; Yan Z; Qingting W; Haoyang M; Lina Z; Ming Z; Guang Y; Xiaolin L; Purrunsing Y; Ningning W
    Horm Metab Res; 2018 Oct; 50(10):761-767. PubMed ID: 30223287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of Parathyroidectomy on Bone Metabolism and Bone Pain in Patients with Secondary Hyperparathyroidism.
    Schneider R; Steinmetz C; Karakas E; Bartsch DK; Schlosser K
    Eur Surg Res; 2018; 59(1-2):35-47. PubMed ID: 29393259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the Intravenous Calcimimetic Etelcalcetide on Bone Turnover and Serum Fibroblast Growth Factor 23: Post Hoc Analysis of an Open-label Study.
    Shigematsu T; Fukagawa M; Yokoyama K; Akiba T; Fujii A; Odani M; Akizawa T
    Clin Ther; 2018 Dec; 40(12):2099-2111. PubMed ID: 30473399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroidectomy Increases Heart Rate Variability and Leptin Levels in Patients with Stage 5 Chronic Kidney Disease.
    Jiang Y; Shen Z; Zhang J; Xing C; Zha X; Shen C; Zeng M; Yang G; Mao H; Zhang B; Yu X; Sun B; Ouyang C; Ge Y; Zhang L; Cheng C; Zhang J; Yin C; Chen H; Wang N
    Am J Nephrol; 2016; 44(3):245-54. PubMed ID: 27598394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of parathyroidectomy on plasma PTH fragments and heart rate variability in stage 5 chronic kidney disease patients.
    Chen H; Ren W; Gao Z; Zeng M; Tang S; Xu F; Huang Y; Zhang L; Cui Y; Yang G; Qian H; Zhou W; Ouyang C; Gao X; Zhang J; Xiao Y; Zhao B; Wang J; Bian A; Li F; Wan H; Gao W; Wang X; Xing C; Zha X; Wang N
    Ren Fail; 2021 Dec; 43(1):890-899. PubMed ID: 34044733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
    O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
    Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone metabolism markers and hungry bone syndrome after parathyroidectomy in dialysis patients with secondary hyperparathyroidism.
    Ge Y; Yang G; Wang N; Zha X; Yu X; Mao H; Sun B; Zeng M; Zhang B; Xing C
    Int Urol Nephrol; 2019 Aug; 51(8):1443-1449. PubMed ID: 31264087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Susantitaphong P; Vadcharavivad S; Susomboon T; Singhan W; Dumrongpisutikul N; Jakchairoongruang K; Eiam-Ong S; Praditpornsilpa K
    Ren Fail; 2019 Nov; 41(1):326-333. PubMed ID: 31014177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after parathyroidectomy in chronic hemodialysis patients with severe secondary hyperparathyroidism.
    Moldovan D; Racasan S; Kacso IM; Rusu C; Potra A; Bondor C; Patiu IM; Gherman-Căprioară M
    Int Urol Nephrol; 2015 Nov; 47(11):1871-7. PubMed ID: 26377492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease
.
    Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N
    Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between increased serum osteoprotegerin levels and improvement in bone mineral density after parathyroidectomy in hemodialysis patients.
    Zheng CM; Chu P; Wu CC; Ma WY; Hung KC; Hsu YH; Lin YF; Diang LK; Lu KC
    Tohoku J Exp Med; 2012 Jan; 226(1):19-27. PubMed ID: 22156488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroidectomy in patients with chronic kidney disease: Impacts of different techniques on the biochemical and clinical evolution of secondary hyperparathyroidism.
    Albuquerque RFC; Carbonara CEM; Martin RCT; Dos Reis LM; do Nascimento CP; Arap SS; Moysés RMA; Jorgetti V; Montenegro FLM; de Oliveira RB
    Surgery; 2018 Feb; 163(2):381-387. PubMed ID: 29146232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Total parathyroidectomy in treatment of Sagliker syndrome in 10 cases of hemodialysing patients with secondary hyperparathyroidism].
    Zhang L; Yao L; Hua Z; Bian WJ; Li WG
    Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):562-7. PubMed ID: 22041265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis.
    Nagatoya K; Nishimoto K; Shibahara N; Takahashi T; Kanehara H; Ueno N; Yasuda H; Okada S; Ueda H; Hirai K; Inoue T;
    Clin Exp Nephrol; 2015 Oct; 19(5):939-46. PubMed ID: 25504368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum bone markers in ROD patients across the spectrum of decreases in GFR: Activin A increases before all other markers
.
    Lima F; Mawad H; El-Husseini AA; Davenport DL; Malluche HH
    Clin Nephrol; 2019 Apr; 91(4):222-230. PubMed ID: 30862350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between blood bone metabolic biomarkers and anemia in patients with chronic kidney disease.
    Li F; Ye X; Yang G; Huang H; Bian A; Xing C; Tang S; Zhang J; Jiang Y; Chen H; Yin C; Zhang L; Wang J; Huang Y; Zhou W; Wan H; Zha X; Zeng M; Wang N
    Ren Fail; 2023 Dec; 45(1):2210227. PubMed ID: 37170583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.